Navigation Links
Generex Provides Update on Spinout of Antigen Express
Date:9/15/2011

WORCESTER, Mass. and TORONTO, Sept. 15, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today provided an update on the status of the previously announced spinout of its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com).

The Company is in the midst of a detailed and comprehensive review of several transaction opportunities, including both shell companies and operating biotech companies with synergistic intellectual properties, in each case Securities and Exchange Commission registrants and Depository Trust Company eligible companies, into which Antigen Express will be merged.

"We are undertaking our due diligence examination of available alternatives with a view to identifying an appropriate transaction for the Antigen Express spinout," stated Mark Fletcher, Generex President & Chief Executive Officer.  "We will proceed with expedition to negotiate an agreement with the target company, complete the merger of Antigen Express into that company, and conduct an  initial fund raising.  If the merger and the initial fund raising are successful, we will then seek a listing of the merged company's stock on a national stock exchange."

Generex will provide further updates as the transactions progress.

Mr. Fletcher has previously stated regarding the spinout:  "The transformation of Antigen Express into a separate, publicly traded entity is the centerpiece of the Generex strategic development plan.  For too long, Antigen Express and its promising immunotherapeutic vaccine technologies have been overshadowed by the Generex buccal drug delivery platform technologies.  We believe this spinout will help to unlock the true value of this dynamic company for our stockholders as it creates a pure play in immunotherapeutic vaccines for which we have already received an appraisal o
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Generex Biotechnology Corporation
2. Generex Announces That Adjournment will be Sole Matter Considered at Special Meeting of Stockholders on September 17, 2010
3. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
4. Generex Plans Rights Offering to Stockholders Following Reverse Stock Split
5. Generex Scientific Advisor Weighs in on Reverse Stock Split Proposal
6. Generex Provides Additional Reverse Stock Split Information for the Consideration of Stockholders
7. Generex Common Stock to be Quoted on the OTCQB Under the Symbol GNBT Beginning Thursday, October 21, 2010
8. Generex Provides Additional Details for October 21st Live Video Webcast
9. Generex Announces $3.0 Million Capital Investment
10. Generex Announces Publication of Comparative Peptide Vaccine Studies in Peer Review Journal Demonstrating Superiority of AE37 and Presentation at the American Association for Cancer Research
11. Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 AudioNotch is the internet's leading ... the treatment of tinnitus. Patients listen to sound therapy ... a period of weeks to months, their tinnitus volume decreases. ... forms: Notched Music and Notched White Noise. Now, AudioNotch is ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, April ... Location: Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... nonprofit organization solely dedicated to finding a cure for hepatitis ... worldwide, will host its annual Crystal Ball on Friday, April ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... , Jan. 14, 2014 As pet owners drew up their ... of them wrote: "Take better care of my furry companion." Nowadays ... clothes and top-brand carrying cases to take the little canine or ... also feel compelled to buy some pricey toys at the pet ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... 16 Roche (OTCQX:,RHHBY; SWX: ROG.VX; RO.S), a world-leading ... has extended its,offer to acquire all of the outstanding ... ) to 5:00 p.m., New York City time on ... to expire at 5:00,p.m., New York City time, on ...
... Squibb,Company (NYSE: BMY ) will announce results for ... January 31. During a 10 a.m. (ET) conference call,on ... will,address inquiries from investors and analysts., Investors and ... live,webcast of the call at http://www.bms.com/ir or ...
... Statement on 1/11/08, SPOKANE, Wash., Jan. 16 ... the use of estriol in compounded hormone,replacement therapy. While ... medical practice. Cheryle Hart, M.D.,is Mayo Clinic trained and ... by Hart in 1997. She is also the medical ...
Cached Biology Technology:Roche Extends Tender Offer for Ventana 2Roche Extends Tender Offer for Ventana 3Roche Extends Tender Offer for Ventana 4Roche Extends Tender Offer for Ventana 5Bio-Identical Hormone Menopause Doctor Responds to Recent FDA News About Estriol 2
(Date:4/17/2014)... trials to treat tuberculosis could be the basis for ... bacteria, fungal infections and parasites, yet evade resistance, according ... collaborators. , Led by U. of I. chemistry professor ... drug SQ109 attacks the tuberculosis bacterium, how the drug ... to malaria and how targeting multiple pathways reduces ...
(Date:4/17/2014)... chili peppers. Information about archaeological remains of ancient chili ... appearance of words for chili peppers in ancient dialects ... highlight the value of multi-proxy data analysis. Their results ... papers presented in a special feature issue of the ... on plant and animal domestication edited by Dolores Piperno, ...
(Date:4/17/2014)... West Orange, NJ. April 16, 2014. Kessler Foundation ... for $1.8 million from the Department of Defense ... PhD, is principal investigator for the randomized, double-blinded, ... to improve bone and muscle strength after spinal ... Human Performance & Engineering Research at Kessler Foundation. ...
Breaking Biology News(10 mins):Multitarget TB drug could treat other diseases, evade resistance 2Chickens to chili peppers 2Chickens to chili peppers 3Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2
... improved dramatically in water quality and wildlife over the ... of one the largest studies of national trends in ... typically from poorly treated sewage and industrial waste, rivers ... insects such as mayflies and stoneflies that are typical ...
... the largest-ever meeting of tropical biologists congratulated Brazil ... but warned that recent developments could jeopardize that ... lands, and safeguarding ecosystems outside the Amazon rainforest. ... tropical biologists and conservationists met in Bonito, Brazil ...
... playing an essential role in our life. This ECI ... research, development and applications related to water production, wastewater ... the environment, special needs, etc. It will provide a ... for the global membrane community. It will also serve ...
Cached Biology News:Britain's urban rivers bounce back 2Scientists warn Brazil's environmental leadership at risk 2Scientists warn Brazil's environmental leadership at risk 3Advanced Membrane Technology V Conference 2
... is used for agitation and mixing applications such ... destaining of gels and blots, and Southern hybridization. ... and can handle a maximum load of 4.5 ... x 21 cm platforms covered with nonsolid rubber ...
... 2,2′-Azino- bis (3-ethylbenzthiazoline-6-sulfonic Acid) ... concentrations of ABTS and H 2 O 2 ... proprietary stabilizers. Peroxidase substrate that is soluble, safe, ... ABTS ™ develops intense blue-green color that ...
... The new IKATUBE ULTRA TURRAX Tube Disperser ... closed homogenizing system. It offers a cleaner, safer, ... IKATUBE system processes sample volumes from 2 to ... sample type, researchers can choose one of 4 ...
... scattering detector for ambient HPLC. Contains ... hardware for two external devices such ... contains an analog output from the ... chart recorders. Includes an input for ...
Biology Products: